CD33 and Alzheimer disease: Genome-wide association studies (GWAS) have identified AD risk genes CD33 and TREM2 as being linked to immune responses and microglia (Griciuc and Tanzi, 2021), as detailed below in sections “Triggering Receptor Expressed on Myeloid Cells 2 and Others.”